As shown in Figure 4 and Table S7 and S8, overall, both HER2‐low BC and HER2‐zero BC showed significantly higher ERS and PRS than healthy controls (both p values <0.001), while there was no obvious difference between HER2‐low and HER2‐zero BC. This evidence concerns the gene ERBB2 and breast cancer.